PRME compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

PRMEPrime Medicine, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

PRMEPrime Medicine, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

PRME, solidAMGN, dashed

Supply-chain overlap

Revenue flow

PRME: latest quarter is a loss; flow not drawable.Method ›

PRMEPrime Medicine, Inc.

4.72▼−9.92%· post 4.71

Mkt cap—Revenue$1MQ2 FY26Revenue$5MFY25

AMGNAmgen Inc

466.31▲+1.21%· post 466.40

ClosedOct 30 '26

Mkt cap$251.9BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

Compare

ClosedOct 30 '26

PRMEPrime Medicine, Inc.

AMGNAmgen Inc

4.72▼−9.92%post 4.71

Price

466.31▲+1.21%post 466.40

—

Mkt cap

$251.9B

Q2 FY26$1M

Revenue

$10.1BQ2 FY26

FY25$5M

Revenue

$36.8BFY25

PRME4.72▼−9.92%vsAMGN466.31▲+1.21%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PRME 11

BMYBMScustomer

BEAMBeamsupplier

—Alpine Rewardsunlistedsupplier

—Broad Instituteunlistedsupplier

7 more · PRME chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›